Conditional BCL-2 Expression in Fibroblasts Promotes Persistent Pulmonary Fibrosis which is Reversible by Therapeutic BCL-2 InhibitionElizabeth F. Redente(National Jewish Health), David W. H. Riches(National Jewish Health)Nature CommunicationsFebruary 28, 202610.1038/s41467-026-69865-4Cited by 0SaveCiteExport RISWatch citationsRelated PapersInhibition of antiapoptotic BCL-2 proteins with ABT-263 induces fibroblast apoptosis, reversing persistent pulmonary fibrosis|JCI Insight|2023|67Loss of Fas signaling in fibroblasts impairs homeostatic fibrosis resolution and promotes persistent pulmonary fibrosis|JCI Insight|2020|61